ASEAN is projected to become the fourth-largest economy by 2030. Untapping ASEAN Business Opportunities and Partnerships.

About The Company

Yakin Medic Sdn. Bhd.

Sector: Biotechnology Industry: Healthcare Sub-Industry: Cell Therapy - Stem cells, Fibroblasts

Yakin Medic Sdn. Bhd. is a biotechnology company, specializing in Cell and Gene therapy products for anti-frailty and wellness purposes. The mission of the company is to establish as a pioneer in this field in Malaysia, with stem cells as core business.

The primary product of the company had been adult human cells ‘Dermal Fibroblasts,’ to address age-related skin problems. From there, the company emerges into the wellness programs with the help of Mesenchymal stem cells, manufactured using a patented advanced technology. Both the Fibroblasts and Mesenchymal cells are at the pre-commercialization stage, targeting wellness center, clinics, and hospital as primary customers.

With the advancement of modern medical science, average longevity has increased in almost every population around the world. As such, the number of elderly people in any society is higher than before. Thus, the demand for anti-frailty treatment in the global market is created, and Yakin’s vision and mission are to meet that demand.